AEPCX | AWWIX | AEPCX / AWWIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 6 years | - |
Gain YTD | -1.247 | 4.604 | -27% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 126B | 595M | 21,176% |
Annual Yield % from dividends | 0.81 | 1.10 | 74% |
Returns for 1 year | -0.11 | 5.90 | -2% |
Returns for 3 years | -13.91 | 4.33 | -322% |
Returns for 5 years | -1.83 | 21.89 | -8% |
Returns for 10 years | 14.02 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DRLYX | 8.22 | 0.13 | +1.61% |
BNY Mellon Developed Markets RE Scs - Y | |||
FZROX | 20.54 | 0.23 | +1.13% |
Fidelity ZERO Total Market Index | |||
MEYWX | 11.05 | 0.10 | +0.91% |
Manning & Napier Equity Series W | |||
HGHSX | 39.04 | 0.31 | +0.80% |
Hartford Healthcare R4 | |||
IDVSX | 24.19 | 0.11 | +0.46% |
Morgan Stanley Inst Intl Advtg R6 |